Skip to main content
. Author manuscript; available in PMC: 2021 Nov 1.
Published in final edited form as: Cancer Treat Rev. 2020 Aug 20;90:102091. doi: 10.1016/j.ctrv.2020.102091

Table 1.

Tumors Commonly Associated with BAP1 Germline Alterations (BAP1-Tumor Predisposition Syndrome (BAP1-TPDS)).[32]

Patients with Germline BAP1 Alterations (Total, N=215) Median Age of Onset (years)
Tumor Type No. of tumors of specific class, N % of patients with tumor of specific class Tumors with Germline BAP1 Mutations Sporadic Tumors
Uveal melanoma 60 28% 59 62
Malignant mesothelioma 48 22% 46 74
Cutaneous melanoma 38 18% 43 61
Renal cell carcinoma 20 9% 51 64
Basal cell carcinoma 14 7% 41 75
BAP1-inactivated melanocytic tumor (BIMT)* 40 75% 31 24
*

Of the total 215 patients with BAP1-TPDS, 53 underwent the necessary total body skin examination to diagnose BIMT; of these, 40 patients (75%) had a positive diagnosis for one or more BIMTs.